MOREPEN LABORATORIES LIMITED

investor-update

Q1 FY27: commercial execution and record quarterly results

2026-08-04

Revenue of INR 5,753 million and EBITDA of INR 877 million reported for Q1 FY27.

Revenue of INR 5,753 million and EBITDA of INR 877 million reported for Q1 FY27.